N-(3-pyridyl)-Indomethacin amide

- Overview
  - Please contact us at for specific academic pricing.
    
    Background
    
    N-(3-pyridyl)-Indomethacin amide is a reversible, potent and selective COX-2 inhibitor [1]. Cyclooxygenase (COX) is an enzyme responsible for formation of prostanoids, including thromboxane and prostaglandins such as prostacyclin. COX-1 is the constitutive isoform and is mainly responsible for the synthesis of cytoprotective prostaglandins in the gastrointestinal tract (GI) and of the proaggregatory thromboxane in blood platelets. COX-2 is inducible and short-lived that is stimulated by endotoxin, cytokines, and mitogens. COX-2 plays important roles in prostaglandin biosynthesis in inflammatory cells the central nervous system [1]. N-(3-pyridyl)-indomethacin amide (N-3PyIA) is a reversible, potent and selective COX-2 inhibitor that inhibits human recombinant COX-2 and ovine COX-1 with IC50 values of 0.052 and >66 μM, respectively. It is over 1300 times less potent as an inhibitor of ovine COX-1. N-(3-pyridyl)-indomethacin amide is the 3-pyridyl amide derivative of indomethacin that shows selective against COX-2 [1].
- Properties
  - Alternative Name
    
    N-3PyIA; N-(3-pyridyl)-1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetamide
    
    CAS Number
    
    261766-29-4
    
    Molecular Formula
    
    C24H20ClN3O3
    
    Molecular Weight
    
    433.9
    
    Appearance
    
    A crystalline solid
    
    Purity
    
    98.00%
    
    Solubility
    
    ≤3mg/ml in ethanol;3mg/ml in DMSO;3mg/ml in dimethyl formamide
    
    Storage
    
    Store at -20°C
    
    * For Research Use Only

N-(3-pyridyl)-Indomethacin amide

N-(3-pyridyl)-Indomethacin amide

Background

We Also Recommend

Glycerophospho-N-Oleoyl Ethanolamine

Lasofoxifene (tartrate)

N-(4-acetamidophenyl)-Indomethacin amide